<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Mail.com: Ranbaxy Laboratories Ltd.</title>
    <link>http://www.mail.com/companies/880118-ranbaxy-laboratories-ltd.html</link>
    <description>Mail.com - the best personalized free web-based Email</description>
    <language>en</language>
    <dc:language>en</dc:language>
    <image>
      <title>Mail.com: Ranbaxy Laboratories Ltd.</title>
      <url>http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png</url>
      <link>http://www.mail.com/companies/880118-ranbaxy-laboratories-ltd.html</link>
    </image>
    <item>
      <title>Drug manufacturer agrees to $500 million penalty</title>
      <link>http://www.mail.com/business/economy/2082222-drug-manufacturer-agrees-to-500-penalty.html</link>
      <description>WASHINGTON (AP) — A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. 
                   Federal prosecutors say the guilty plea by Ranbaxy USA Inc...</description>
      <pubDate>Tue, 14 May 2013 03:33:52 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/2082222-drug-manufacturer-agrees-to-500-penalty.html</guid>
      <dc:date>2013-05-14T03:33:52Z</dc:date>
    </item>
    <item>
      <title>Drugmaker Ranbaxy halts generic Lipitor production</title>
      <link>http://www.mail.com/business/economy/1734216-drugmaker-ranbaxy-halts-generic-lipitor-production.html</link>
      <description>Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. It was Ranbaxy's second recall of the drug, called atorvastatin, since August. 
                   The Food and Drug Administration...</description>
      <pubDate>Fri, 30 Nov 2012 21:50:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/business/economy/1734216-drugmaker-ranbaxy-halts-generic-lipitor-production.html</guid>
      <dc:date>2012-11-30T21:50:00Z</dc:date>
    </item>
    <item>
      <title>Ranbaxy recalls generic Lipitor doses</title>
      <link>http://www.mail.com/scitech/health/1719994-ranbaxy-recalls-generic-lipitor-doses.html</link>
      <description>TRENTON, N.J. (AP) — Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company's medicines. 
                   Ranbaxy, a subsidiary of Ranbaxy Laboratories Lt...</description>
      <pubDate>Mon, 26 Nov 2012 14:52:00 GMT</pubDate>
      <guid isPermaLink="false">http://www.mail.com/scitech/health/1719994-ranbaxy-recalls-generic-lipitor-doses.html</guid>
      <dc:date>2012-11-26T14:52:00Z</dc:date>
    </item>
  </channel>
</rss>

